SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-003169
Filing Date
2023-03-08
Accepted
2023-03-08 17:10:57
Documents
15
Period of Report
2023-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pmn-20230308x8k.htm   iXBRL 8-K 37501
2 EX-99.1 pmn-20230308xex99d1.htm EX-99.1 128717
3 GRAPHIC pmn-20230308xex99d1001.jpg GRAPHIC 6902
  Complete submission text file 0001558370-23-003169.txt   321051

Data Files

Seq Description Document Type Size
4 EX-101.SCH pmn-20230308.xsd EX-101.SCH 3952
5 EX-101.DEF pmn-20230308_def.xml EX-101.DEF 2872
6 EX-101.LAB pmn-20230308_lab.xml EX-101.LAB 17907
7 EX-101.PRE pmn-20230308_pre.xml EX-101.PRE 11838
9 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20230308x8k_htm.xml XML 4994
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 23717004
SIC: 2834 Pharmaceutical Preparations